Helicase–primase inhibitors as the potential next generation of highly active drugs against herpes simplex viruses

Author： Birkmann Alexander   Hewlett Guy   Rübsamen-Schaeff Helga   Zimmermann Holger  

Publisher： Future Medicine

ISSN： 1746-0794

Source： Future Virology, Vol.6, Iss.10, 2011-10, pp. : 1199-1209

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Helicase-primase inhibitors promising in HSV infection

By  

Inpharma, Vol. 1, Iss. 1337, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

The DNA helicase–primase complex as a target for herpes viral infection

By Weller Sandra K   Kuchta Robert D  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 10, 2013-10 ,pp. : 1119-1132

Informa Healthcare

Access to resources Recommend Favorite

A short commentary on the review by Weller and Kuchta: the DNA helicase–primase complex as a target for herpes virus infection

By Field Hugh J  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 10, 2013-10 ,pp. : 1113-1114

Informa Healthcare

Access to resources Recommend Favorite

Prophylactic Vaccine Strategies and the Potential of Therapeutic Vaccines Against Herpes Simplex Virus

By  

Current Pharmaceutical Design, Vol. 13, Iss. 19, 2007-07 ,pp. : 1975-1988

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery, SAR and Medicinal Chemistry of Herpesvirus Helicase Primase Inhibitors

By  

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 3, Iss. 1, 2004-01 ,pp. : 69-83

Bentham Science Publishers

Access to resources Recommend Favorite